نتایج جستجو برای: tag72 nanobody

تعداد نتایج: 699  

Journal: :modares journal of medical sciences: pathobiology 2011
fatemeh safarian fatemeh rahbarizadeh said amanpour zahra sharifzadeh

objective: the objective of this study is to develop and assess targeted pamam-peg nanocarrier with anti-tag72 nanobody for t-bid gene coding construct delivery into the human colonic adenocarcinoma cells. materials and methods: nanobody (nb) coding sequence was subcloned into psj expression vector for large-scale production and then nb was purified by ni++ affinity chromatography. sds-page an...

ژورنال: دانشور پزشکی 2012
اصل رسولی, نگار, احمدوند, داود , جعفری ایری سفلی, فرنوش , رهبری‌زاده, فاطمه ,

 Background and Objectives: The aim of this study was preparation of polyethyleneimine (PEI) nanoparticles targeted with anti-TAG72 nanobody for delivery of t-Bid gene construct into the human colonic adenocarcinoma cells. Materials and Methods: First of all, purified recombinant nanobody was verified by SDS-PAGE, western blotting and ELISA. Targeted polyplexes were constructed by reacting ...

Journal: :iranian journal of basic medical sciences 0
vida homayouni immunology department, faculty of medicine, isfahan university of medical sciences, isfahan, iran mazdak ganjalikhani-hakemi immunology department, faculty of medicine, isfahan university of medical sciences, isfahan, iran abbas rezaei immunology department, faculty of medicine, isfahan university of medical sciences, isfahan, iran hossein khanahmad genetic department, faculty of medicine, isfahan university of medical sciences, isfahan, iran mahdi behdani biotechnology research center, biotechnology department, venom & bio-therapeutics molecules lab, pasteur institute of iran, tehran, iran fatemeh kazemi lomedasht biotechnology research center, biotechnology department, venom & bio-therapeutics molecules lab, pasteur institute of iran, tehran, iran

objective(s): as t-cell immunoglobulin and mucin domain 3 (tim-3) is an immune regulatory molecule; its blocking or stimulating could alter the pattern of immune response towards a desired condition. based on the unique features of nanobodies, we aimed to construct an anti-tim-3 nanobody as an appropriate tool for manipulating immune responses for future therapeutic purposes. materials and meth...

2016
Yongzhong Wang Zhen Fan Lei Shao Xiaowei Kong Xianjuan Hou Dongrui Tian Ying Sun Yazhong Xiao Li Yu

Owing to peculiar properties of nanobody, including nanoscale size, robust structure, stable and soluble behaviors in aqueous solution, reversible refolding, high affinity and specificity for only one cognate target, superior cryptic cleft accessibility, and deep tissue penetration, as well as a sustainable source, it has been an ideal research tool for the development of sophisticated nanobiot...

2018
Fatemeh Kazemi-Lomedasht Serge Muyldermans Mahdi Habibi-Anbouhi Mahdi Behdani

Objectives Nanobodies, the single domain antigen binding fragments of heavy chain-only antibodies occurring naturally in camelid sera, are the smallest intact antigen binding entities. Their minimal size assists in reaching otherwise largely inaccessible regions of antigens. However, their camelid origin raises a possible concern of immunogenicity when used for human therapy. Humanization is a ...

2016
Michael B. Braun Bjoern Traenkle Philipp A. Koch Felix Emele Frederik Weiss Oliver Poetz Thilo Stehle Ulrich Rothbauer

Nanobodies are highly valuable tools for numerous bioanalytical and biotechnical applications. Here, we report the characterization of a nanobody that binds a short peptide epitope with extraordinary affinity. Structural analysis reveals an unusual binding mode where the extended peptide becomes part of a β-sheet structure in the nanobody. This interaction relies on sequence-independent backbon...

Objective(s): Nanobodies, the single domain antigen binding fragments of heavy chain-only antibodies occurring naturally in camelid sera, are the smallest intact antigen binding entities. Their minimal size assists in reaching otherwise largely inaccessible regions of antigens. However, their camelid origin raises a possible concern of immunogenicity when used for human therapy. Humanization is...

2016
Vida Homayouni Mazdak Ganjalikhani-hakemi Abbas Rezaei Hossein Khanahmad Mahdi Behdani Fatemeh Kazemi Lomedasht

OBJECTIVES As T-cell immunoglobulin and mucin domain 3 (TIM-3) is an immune regulatory molecule; its blocking or stimulating could alter the pattern of immune response towards a desired condition. Based on the unique features of nanobodies, we aimed to construct an anti-TIM-3 nanobody as an appropriate tool for manipulating immune responses for future therapeutic purposes. MATERIALS AND METHO...

2017
Tiansen Li Meiling Huang Hongran Xiao Guoqi Zhang Jinhua Ding Peng Wu Hui Zhang Jinliang Sheng Chuangfu Chen

Bovine viral diarrhea-mucosal disease (BVD-MD) is caused by bovine viral diarrhea virus (BVDV), and results in abortion, stillbirth, and fetal malformation in cows. Here, we constructed the phage display vector pCANTAB 5E-VHH and then transformed it into Escherichia coli TG1-competent cells, to construct an initial anti-BVDV nanobody gene library. We obtained a BVDV-E2 antigen epitope bait prot...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2014
Marek Pruszynski Eftychia Koumarianou Ganesan Vaidyanathan Hilde Revets Nick Devoogdt Tony Lahoutte H Kim Lyerly Michael R Zalutsky

UNLABELLED Nanobodies are approximately 15-kDa proteins based on the smallest functional fragments of naturally occurring heavy chain-only antibodies and represent an attractive platform for the development of molecularly targeted agents for cancer diagnosis and therapy. Because the human epidermal growth factor receptor type 2 (HER2) is overexpressed in breast and ovarian carcinoma, as well as...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید